News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Depomed, Inc. (DEPO) And Madaus Enter Into Agreement For ProQuin XR In Europe



11/29/2005 10:51:42 AM

MENLO PARK, Calif. & PADOVA, Italy--(BUSINESS WIRE)--Nov. 29, 2005--Depomed, Inc. (Nasdaq: DEPO) and Madaus S.r.l. today announced that the companies have entered into a distribution and supply agreement for ProQuin(R) XR, Depomed's once-daily, extended release formulation of the antibiotic ciprofloxacin.

Read at BioSpace.com
Read at AP


comments powered by Disqus
BioSpace.com
AP
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES